EP0246540A3
Implant preparations for delivery of bioactive macromolecules
Abstract
Implant preparations capable of sustained action when inserted are comprised of powder of natural lipoidal substance in thorough admixture with bioactive macromolecule, followed by compression under pressure into a disc or rod that can be broken and used in small pieces as well.
Term
Term ended
Projected expiry passed 12 May 2007, 19.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both waysCites: the store holds 3 of 4
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0158277A2 | Cites | European Patent Office (EPO) | Y | Search report |
| DE3523454A1 | Cites | Germany | YP | Search report |
| US4452775A | Cites | United States of America | X | Search report |
| CHEMICAL ABSTRACTS, vol. 83, no. 1, 14th July 1975, page 344, abstract no. 15597n, Columbus, Ohio, US; S.P. PATEL et al.: "Use of cholesterol cholesteryl acetate and beta-sitosterol as specialized lipid carriers for oral and implantation depot therapy"; & DISS. ABSTR. INT.B. 1975, 35(8) 4013-4014 | Non-patent | – | – | Search report |
| PHARMACEUTICA ACTA HELVETIAE, vol. 56, no. 4,5, 1981, Zürich, CH; E. DOELKER et al.: "Formulation des comprimés à libération prolongée III. Matrices lipidiques" | Non-patent | – | – | Search report |
17 members in 10 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 509526 | Canada | A | |
| 509526 | Canada | A | |
| 509526 | Canada | – | |
| 509526 | – | – | – |
| CA19860509526 | – | – | – |
Members17
| Document | Office | Kind | |
|---|---|---|---|
| DK251287D0 | Denmark | D0 | |
| DK251287A | Denmark | A | |
| EP0246540A2 | European Patent Office (EPO) | A2 | |
| JPS6322012A | Japan | A | |
| EP0246540A3This record | European Patent Office (EPO) | A3 | |
| AU7108987A | Australia | A | |
| CA1257199A | Canada | A | |
| AU603793B2 | Australia | B2 | |
| US5110595A | United States of America | A | |
| EP0246540B1 | European Patent Office (EPO) | B1 | |
| AT79024T | Austria | T | |
| ATE79024T1 | Austria | T1 | |
| DE3780862D1 | Germany | D1 | |
| DE3780862T2 | Germany | T2 | |
| GR3005395T3 | Greece | T3 | |
| ES2051707T3 | Spain | T3 | |
| US5939380A | United States of America | A |
41 legal events, as 4 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Patent revokedRevoked27W | 27W | EP | |
| Gb: patent revoked under art. 102 of the ep convention designating the uk as contracting stateRevoked970911GBPR | GBPR | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Annulment or lapse due to non-payment of feesLapsed3005395MM2A | MM2A | GR | |
| Patent revokedRevokedORIGINAL CODE: 0009271RDAG | RDAG | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT REVOKEDSTAA | STAA | EP | |
| Patent revokedRevokedORIGINAL CODE: EPIDOS REVORDAH | RDAH | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Validation in greece3005395FG4A | FG4A | GR | |
| Fr: translation filedET | ET | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0246540
- Publication, DOCDB
- 0246540
- Publication, EPODOC
- EP0246540
- Application
- 87106859
- Application, DOCDB
- 87106859
- Application, EPODOC
- EP19870106859
Titles3
- English
- Implant preparations for delivery of bioactive macromolecules
- French
- Implants pour la libération de macromolécules bioactives
- German
- Implantate zur Abgabe biologisch aktiver Makromoleküle
Classification
- CPC, 3
- A61K9/0024
- A61K9/2013
- A61P3/10
- IPC, 14
- A61K47 36
- A61K9 00
- A61K9 22
- A61K38 00
- A61K38 27
- A61K38 28
- A61K47 06
- A61K47 12
- A61K47 14
- A61K47 28
- A61K47 42
- A61K47 44
- A61L27 00
- A61P3 10
Designated states1
- Contracting states, 1
- Sweden